These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 8752905)
1. The role of the B7-1a molecule, an alternatively spliced form of murine B7-1 (CD80), on T cell activation. Inobe M; Aoki N; Linsley PS; Ledbetter JA; Abe R; Murakami M; Uede T J Immunol; 1996 Jul; 157(2):582-8. PubMed ID: 8752905 [TBL] [Abstract][Full Text] [Related]
2. Costimulation of IL-4 production by murine B7-1 and B7-2 molecules. Natesan M; Razi-Wolf Z; Reiser H J Immunol; 1996 Apr; 156(8):2783-91. PubMed ID: 8609397 [TBL] [Abstract][Full Text] [Related]
3. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Kennedy MK; Mohler KM; Shanebeck KD; Baum PR; Picha KS; Otten-Evans CA; Janeway CA; Grabstein KH Eur J Immunol; 1994 Jan; 24(1):116-23. PubMed ID: 7517359 [TBL] [Abstract][Full Text] [Related]
4. MRC OX-2 defines a novel T cell costimulatory pathway. Borriello F; Lederer J; Scott S; Sharpe AH J Immunol; 1997 May; 158(10):4548-54. PubMed ID: 9144466 [TBL] [Abstract][Full Text] [Related]
5. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86. Schweitzer AN; Borriello F; Wong RC; Abbas AK; Sharpe AH J Immunol; 1997 Mar; 158(6):2713-22. PubMed ID: 9058805 [TBL] [Abstract][Full Text] [Related]
6. B7-1-HSA (CD80-CD24), a recombinant hybrid costimulatory molecule retains ligand binding and costimulatory functions. Wang YC; Sashidharamurthy R; Nagarajan S; Selvaraj P Immunol Lett; 2006 Jun; 105(2):185-92. PubMed ID: 16621031 [TBL] [Abstract][Full Text] [Related]
7. In vivo immunogenicity of osteosarcoma cells that express B7-1a, an alternatively spliced form of B7-1. Nagamori M; Kawaguchi S; Murakami M; Wada T; Inobe M; Ishii S; Uede T Anticancer Res; 2002; 22(4):2009-13. PubMed ID: 12174878 [TBL] [Abstract][Full Text] [Related]
8. Requirements for stimulation or anergy induction in alloreactive human T cell clones. Pawelec G; Kalbacher H; Pohla H; Boshell M; Max H; Friccius H; Adibzadeh M; Hambrecht A; Sansom D Cell Immunol; 1994 Oct; 158(1):241-52. PubMed ID: 7522128 [TBL] [Abstract][Full Text] [Related]
9. Molecular cloning and comparative analysis of the rhesus macaque costimulatory molecules CD80 (B7-1) and CD86 (B7-2). Zhang D; Johnson RP Cell Immunol; 1997 Apr; 177(1):9-17. PubMed ID: 9140091 [TBL] [Abstract][Full Text] [Related]
10. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production. Schweitzer AN; Sharpe AH J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334 [TBL] [Abstract][Full Text] [Related]
12. Inflammatory cytokines IFN-gamma plus TNF-alpha induce regulated expression of CD80 (B7-1) but not CD86 (B7-2) on murine fibroblasts. Pechhold K; Patterson NB; Craighead N; Lee KP; June CH; Harlan DM J Immunol; 1997 May; 158(10):4921-9. PubMed ID: 9144510 [TBL] [Abstract][Full Text] [Related]
13. Molecular cloning and expression of early T cell costimulatory molecule-1 and its characterization as B7-2 molecule. Chen C; Gault A; Shen L; Nabavi N J Immunol; 1994 May; 152(10):4929-36. PubMed ID: 7513726 [TBL] [Abstract][Full Text] [Related]
14. Intraperitoneal Echinococcus multilocularis infection in C57BL/6 mice affects CD40 and B7 costimulator expression on peritoneal macrophages and impairs peritoneal T cell activation. Mejri N; Gottstein B Parasite Immunol; 2006 Aug; 28(8):373-85. PubMed ID: 16879309 [TBL] [Abstract][Full Text] [Related]
15. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells. Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772 [TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody 2D10 recognizes a novel T cell costimulatory molecule on activated murine B lymphocytes. Chen C; Faherty DA; Gault A; Connaughton SE; Powers GD; Godfrey DI; Nabavi N J Immunol; 1994 Mar; 152(5):2105-14. PubMed ID: 7510738 [TBL] [Abstract][Full Text] [Related]
17. Subcellular localization of CD80 receptors is dependent on an intact cytoplasmic tail and is required for CD28-dependent T cell costimulation. Doty RT; Clark EA J Immunol; 1996 Oct; 157(8):3270-9. PubMed ID: 8871621 [TBL] [Abstract][Full Text] [Related]
18. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation. Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381 [TBL] [Abstract][Full Text] [Related]
19. Molecular cloning and mRNA tissue-expression of two isoforms of the ovine costimulatory molecule CD80 (B7-1). Terzo EA; Alzueta M; Amorena B; de Andrés DF; de la Lastra JM Vet Immunol Immunopathol; 2005 Jan; 103(1-2):9-19. PubMed ID: 15626458 [TBL] [Abstract][Full Text] [Related]
20. Lack of CD80 expression by fibroblast-like synoviocytes leading to anergy in T lymphocytes. Corrigall VM; Solau-Gervais E; Panayi GS Arthritis Rheum; 2000 Jul; 43(7):1606-15. PubMed ID: 10902766 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]